The number of MC07 (CD38+/CD196+/IgD−) B cells was significantly higher in the SLE group (HCs: 0.914%; RA: 0.802%; SSc: 0.988%; SLE: 2.638%) (Figure 11B). This evidence concerns the gene CD38 and systemic sclerosis.